We are driven by an approach of not just synthesizing APIs, but creating better pharmaceutical outcomes. Therefore every product we create, is a product born to advance the future of the final dose.

We are one among the Indian pharmaceutical companies who see tremendous value in investing in Research & Development (R&D). Our in-house research centre accredited by DSIR (Department of Scientific and Industrial Research), Govt. of India, has been the driving force to develop products.

Our early investments in R&D enabled us to make technology our key differentiator and develop a basket of robust products for diverse markets across the world. Moreover, our laboratories are fully equipped with fume hoods and necessary analytical setup to take care of synthetic research from gram scale to kilogram scale.

The development work is initiated within the framework of a CDA (Confidentiality Disclosure Agreement) and utmost care is taken to protect our client’s Intellectual Property at all levels. This includes all our employees, who are covered under confidentiality agreements irrespective of designations.

Our scientists work closely with our business development team to generate innovative concepts and ideas, exploiting both market needs and synergies across therapeutic areas.

Copyright © 2017 SPC Lifesciences. All Rights Reserved.